Tal Michael G, Covey Anne, Qaqish Shaker, Livne Ron, Klass Darren
Division of Interventional Radiology, Hadassah Medical Center, Jerusalem, Israel.
Memorial Sloan Kettering Cancer Center, New York, NY, USA.
J Vasc Access. 2025 Jan;26(1):211-216. doi: 10.1177/11297298231212227. Epub 2023 Nov 23.
Guidewire-facilitated access to peripheral vessels is commonplace in vascular access, but guidewire insertion into small vessels, such as the radial and distal radial arteries, can still be challenging. Failure to gain access on the first attempt may contribute to increased risks of procedural complications, such as vessel dissection, spasm, and occlusion. This research assessed the safety and efficacy of radial and distal radial artery access using a novel, FDA-cleared, small-core-diameter guidewire with an articulating tip, under ultrasound guidance.
This was a prospective, single-arm, single-center trial. Patients in need of vascular access were screened for participation and enrolled in the study. Guidewire insertion was attempted by four physicians (three interventional radiologists and an interventional nephrologist) at 162 arterial sites-65 radial and 97 distal radial, having a mean diameter of 2.0 mm.
First-attempt successful placement of the guidewire in the artery occurred at 87.6% of access sites (142/162) and differences in the success rate between the radial and distal radial arteries or between vessels with diameter smaller or larger than 2 mm were not observed (62/68 and 67/77, respectively; = 0.6). Four of the five reported adverse events were unrelated to the study device or procedure. Two of the three distal radial artery spasms occurred before the guidewire was used. The other two events were a radial artery spasm, and a distal radial artery site hematoma. All adverse events resolved spontaneously.
First-attempt placement of a novel articulating tip guidewire in the radial and distal radial arteries occurred at a high rate in our study and was not associated with safety concerns.
在血管通路建立中,导丝辅助进入外周血管很常见,但将导丝插入桡动脉和桡动脉远端等小血管仍具有挑战性。首次尝试未能成功进入血管可能会增加诸如血管夹层、痉挛和闭塞等手术并发症的风险。本研究评估了在超声引导下,使用一种经美国食品药品监督管理局(FDA)批准的、具有可弯曲尖端的新型小芯径导丝进入桡动脉和桡动脉远端的安全性和有效性。
这是一项前瞻性、单臂、单中心试验。筛选需要建立血管通路的患者参与研究。由四名医生(三名介入放射科医生和一名介入肾病科医生)在162个动脉部位尝试插入导丝,其中65个桡动脉部位和97个桡动脉远端部位,平均直径为2.0毫米。
导丝首次尝试成功置入动脉的成功率为87.6%(142/162),未观察到桡动脉和桡动脉远端之间或直径小于或大于2毫米的血管之间成功率的差异(分别为62/68和67/77;P = 0.6)。报告的五例不良事件中有四例与研究器械或操作无关。三例桡动脉远端痉挛中有两例发生在使用导丝之前。另外两例事件分别是桡动脉痉挛和桡动脉远端部位血肿。所有不良事件均自行缓解。
在我们的研究中,新型可弯曲尖端导丝首次尝试置入桡动脉和桡动脉远端的成功率很高,且不存在安全问题。